Monitoring initial response to Angiotensin-converting enzyme inhibitor-based regimens: an individual patient data meta-analysis from randomized, placebo-controlled trials.
about
Power to identify a genetic predictor of antihypertensive drug response using different methods to measure blood pressure response.Effects of additional blood pressure and lipid measurements on the prediction of cardiovascular risk.Variability in response to albuminuria-lowering drugs: true or random?
P2860
Monitoring initial response to Angiotensin-converting enzyme inhibitor-based regimens: an individual patient data meta-analysis from randomized, placebo-controlled trials.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Monitoring initial response to ...... ed, placebo-controlled trials.
@ast
Monitoring initial response to ...... ed, placebo-controlled trials.
@en
type
label
Monitoring initial response to ...... ed, placebo-controlled trials.
@ast
Monitoring initial response to ...... ed, placebo-controlled trials.
@en
prefLabel
Monitoring initial response to ...... ed, placebo-controlled trials.
@ast
Monitoring initial response to ...... ed, placebo-controlled trials.
@en
P2093
P50
P1433
P1476
Monitoring initial response to ...... ed, placebo-controlled trials.
@en
P2093
Bruce C Neal
Katy J L Bell
Stephen Macmahon
Willem J Remme
P304
P356
10.1161/HYPERTENSIONAHA.110.152421
P407
P50
P577
2010-07-12T00:00:00Z